EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.31−0.01 (-4.23%)
Close on Nov 13, 2026Market cap $26.38MP/E –Yield –
EyePoint ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
EyePoint's ebitda for the twelve months ending Sep 30, 2026 was -$349.04M. For fiscal 2025 it was -$241.13M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$241.13M | – |
| FY2024 | Dec 31, 2024 | -$144.31M | – |
| FY2023 | Dec 31, 2023 | -$74.60M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$96.11M | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$96.69M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$86.59M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$69.65M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$61.45M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$61.69M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$48.34M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$44.77M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$32.34M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$34.18M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$33.02M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$16.24M | – |
See a number that looks wrong?